Cambia named in top 100 NGO’s by The Global Journal

For the second year in a row, Cambia has been named as one of the Top 100 NGO’s by The Global Journal. Overall, Cambia was ranked number 54, up from number 86 last year. In the Technology Sector, Cambia was ranked second.

The Journal wrote that “Cambia is energetically and ambitiously working to democratize scientific innovation, most notably through the ‘Patent Lens’ – an open access, Gates Foundation-backed online facility dedicated to mapping global patent landscapes.”

With first the Patent Lens and now its successor, the Lens, Cambia is working to lower the barriers to entry for innovation across all sectors.

Patent system has been sympathetic to “investing communities”

In the recent Myriad case, which was decided on August 16, 2012, The majority opinion held that traditionally the patent system has been sympathetic to “investing communities” and the question of whether genes should be a patentable or Not patentable subject matter is a policy question and up to Congress (NOT the courts) to answer.

Judge Bryson, the dissenting in part Judge, responded that the court received amicus brief from the justice department asking the court not to grant patents on isolated DNA, i. e. the government is asking the court to resolve this issue. According to him:

“Broad claims to genetic material present a significant obstacle to the next generation of innovation in genetic medicine—multiplex tests and whole-genome sequencing. New technologies are being developed to sequence many genes or even an entire human genome rapidly, but firms developing those technologies are encountering a thicket of patents.”

Disclosure of sequences in patent documents is a requirement under the current patent law system, however, a few patent offices make the information computer searchable and available to the public freely of charge. The Biological patenting team of the Lens project built a platform to render that information more accessible to and usable by diverse innovators. Check our new product, PatSeq Explorer that allows users to navigate patent sequences that mapped onto the human genome or as a matter of fact many other genomes in the coming future.

Patents and Innovation in the US

Columnist Joe Nocera recently interviewed Judge Richard Posner on the topic of patent law and lawsuits in the U.S. for the New York Times (article). Judge Posner is possibly the most respected living judge in the U.S. – even more so than most members of the Supreme Court. For nearly 40 years, Judge Posner has written extensively on the application of economic principles to various legal issues. Recently, Judge Posner “decided it would be fun to do patent trials,” and so he has increasingly volunteered to hear cases involving patent disputes.

His attention to patent issues comes at a time when many in the technology sector regard patents as tax on innovation, rather than an incentive to innovation as envisioned in the U.S. Constitution. While recognizing that patents have a place in innovative industries such as pharmaceuticals, Judge Posner argues that patents serve no useful economic purpose in other sectors, such as smartphones: “When you are dealing with products that have very short lives, you often don’t need patents because by the time competitors wise up, you’ve moved on.”

Judge Posner recently applied this logic to a lawsuit between two of the most hyper-litigious players in the smartphone sector, Apple and Motorola. Dismissing the case with prejudice, he wrote that neither party was able to adequately demonstrate that they were entitled to any sort of monetary damages. Meanwhile, he also noted that, having committed to license smartphone technology on “fair, reasonable and non discriminatory” (FRAND) terms, Motorola could hardly argue that an injunction would be necessary because monetary damages would not be sufficient compensation.

Apple has appealed the decision.

2012 PIUG Conference

The 2012 PIUG conference began with a speech entitled “Why I Hate Patents.” The speaker, a venture capitalist, lamented that the U.S. patent regime, at least in the areas of computer science and business methods, has had the opposite of its intended effect: it actually stifles innovation and hinders economic growth. Judging from the applause and questions that followed, the speech was warmly received, and served as a useful reminder that the patent search community is not necessarily pro patent.

The remainder of the conference presentations and vendors centered on two types of technologies: visualization and document grouping. As presented, these platforms were closely interrelated in that the visualization software focused largely on generated representations of document clusters. The visualization demonstrations made for engaging slide presentations, but at least one speaker questioned their utility: a document cluster looks like it imparts a wealth of information and may well impress the patent researchers’ superiors, but what useful information does one actually gain? The document grouping, or search, presentations had as their conceit algorithms that would either search using natural language capability or that would heuristically adapt to the user’s search preferences.

None of the technology platforms really made use of the existing patent classification schemes. Indeed, the one presentation that prominently featured classification schemes was from the EPO, a non-commercial entity. By graphing primary and secondary IPC classifications against time, the EPO presenter was able to demonstrate increasing commercial interest in non-metallic battery technology – an immediate and practical use that virtually none of the for-profit technologies could match. In addition, the EPO’s efforts in assignee disambiguation also appeared to be further along than those of most of the other presenters.

Graphical analysis embedded in any web site

Bar, pie, map and timeline charts created in real time from facets derived from over 80 million patent documents allow exploration and filtering by inventors, applicants, jurisdictions, data type, family and more.

Now with a single click you can copy ‘embed’ code into any HTML page (e.g. web site, blog, intranet) and that analysis is live in your site. And best of all, a single click will take users to the Lens where the evidence that underpins the analysis: the search and filtering parameters, the collections and so on, are right there to learn from, extend, build on and verify.

Adenovirus Delivery

The Illahee Talk: opening the innovation ecology

A few months ago, I had the opportunity to speak in Portland, Oregon on my thoughts of opening the innovation ecology.   The talk was sponsored by a non-profit, Illahee.org.

The talk was introduced by Illahee’s Director, Peter Schoonmaker.   In his  blog post, Peter described his summary of my presentation.

I used the occasion to wax lyrical about the congruence of the hologenome theory of evolution with our work on creating an open and transparent innovation cartography tool.

I tried to find a common thread of ‘biological innovation’ that can guide not only the practical realities of improving health, agriculture, environment and energy, but also the formation of productive and equitable economic and social structures and tools.

The full video of this presentation is available on Vimeo:   Enabling Innovation

van Linschoten: WikiLeaks WritLarge

Linschoten

Jan Huygens van Linschoten

The world’s greatest disruptive act of  Open Access Publishing.

The Dutch are pragmatists.   If there’s a more practical, hard-nosed, outcome-oriented culture that is steeped in business and trade, it might be the Chinese.  But the Dutch are (in so many ways) giants in the history of trade and commerce.

So it may be surprising that what is arguably history’s most disruptive act of creating a ‘commons of knowledge’ that opened up global trade to competition and fair-play came from a Dutchman,   Jan Huygens van Linschoten.

van Linschoten managed in a single act of sharing – in his case the pilfered Portuguese portolans and charts – to open the world of maritime commerce up to free and open competition, stimulating an era of growth and innovation in technology – shipbuilding, sailing, logistics, cartography and navigation – and in business – insurance, investment tools, financial instruments – that changed civilization for ever.

In 1596 or thereabouts, van Linschoten published what had for over a century and a half, the state secrets of Portugal – the maritime cartography of the Indies – West and East.

The Journalistic W’s of innovation cartography

The Classic W’s & H of Innovation

Who (these are real people)

Inventors and Authors on patents, scholarly publications, blogs, grant proposals, business plans, etc; humans who lead initiatives or have key responsibilities.

Which (legal entity, not a person, with apologies to Mitt Romney)

Assignees/owners/ affiliates/ subsidiaries, institutions.  Generally incorporated companies, whether for-profit or non-profit.

What

The subject matter: Title/Abstract/ Specification (Teachings), Claims (Legal Limits), the science, business and regulation of the innovation area.

When

Timeline of inventions, of discoveries, of rights and responsibilities.

Where

Institution of work, country and region of invention, jurisdiction of patent, geography of market.

Why

Ahh.. the big one: The innovation trajectory! what is the jigsaw puzzle (solution set) to which this piece contributes?

&  the

How

The Lens I: What it’s all about

Since its inception twenty five years ago, Cambia has had one goal, even a passion:  to ‘democratize’ science-enabled innovation.

After over twenty years of laboratory work in CambiaLabs, creating, distributing and supporting openly available biological enabling technologies to the global research community –  some of which are amongst the most widely used in the field – we hung up our lab coats and put away our pipettes a few years back.

After over ten years of developing, improving and hosting the Patent Lens,  a hugely popular open web resource, we’re soon to be retiring the site per se.

After almost ten years designing, launching and supporting the BIOS Initiative (Biological Innovation for Open Society, aka Biological Open Source), its new ‘open source’ licensing strategies and its online collaboration platform Bioforge, we pretty much stopped about three years ago.  We turned off bioforge.net.

So we’re quitting?  We’ve run out of steam?    Is this the inevitable demise of the simplistic, science as social enterprise, sharing paradigm?

No bloody way, mate.

We have worked hard, contributed some and learnt much in these decades.   But progress through scientific method is based on having hypotheses *disproved*, not proved.     In the course of this – with careful design and with some grudging willingness be wrong – one gets closer to a truth.

So, doing all this stuff, we identified a common global, structural and systemic opportunity to change the system.

Biological Open Source won’t work without it.   Bioforge didn’t work without it. The Public Sector works very poorly without it.   Small enterprise desperately needs it.  Big business wastes billions to get it.

The biggest inefficiency in the history of post-enlightenment civilization is now entrenched, ubiquitous and feels inevitable.

And its pretty similar to the development of clergy, with their ecclesiastical literature, liturgy and their choke hold on society for the previous millenium.

Put simply,  we have to completely shift the demographics of problem solving by creating a global, open and dynamic resource for ‘innovation cartography’.

We must make it possible for virtually anyone to understand the landscapes of science, intellectual property, business, regulation and other innovation ‘intelligence’ that is necessary to make creative enterprise a possibility at all levels of society.

Creating and using credible dynamic landscapes showing the What, Who, Which, When, Where and Why of science-enabled innovation,  individuals and institutions in public and private sector can envision trajectories, partnerships, strategies, risks and opportunities.   We can engage untapped social, financial and intellectual capital to solve real and compelling problems.

These may be food, health, environment, energy or virtually any other productive economic activity.

The Lens

It would have been unthinkably hard ten years ago.  Five years ago, untenable and outrageously expensive.

Now, its manageable, affordable.  And essential.

The next posts will be about the ‘how’.

But it will *start* with  the world’s patents as the entry point to innovation intelligence.